EDAP TMS S.A. logo
EDAP TMS S.A. EDAP
$ 3.22 0.0%

Quarterly report 2025-Q4
added 04-25-2026

report update icon

EDAP TMS S.A. Book Value 2011-2026 | EDAP

Book value is a financial metric that reflects the value of a company's assets minus its liabilities as of a specific date, according to accounting records. In simple terms, it is the amount that would remain for the owners of the company if all assets were sold and all debts paid off.
What is included in book value
  • Assets — all company resources: real estate, equipment, inventory, cash, accounts receivable, and others.
  • Liabilities — all debts and financial obligations: loans, accounts payable, taxes, and other obligations.
Features of the metric
  • Assessment of the company's "real" value
    Book value shows how much the company is worth according to accounting data, that is, the value of its property taking debts into account.
  • Comparison with market capitalization
    Comparing book value and the market price of shares helps to understand whether the company is overvalued or undervalued by the market.
  • Indicator of financial stability
    If the book value is high, it indicates the company has significant assets, which reduces risks for investors.
  • Key component for financial ratios
    Many metrics, such as the price-to-book ratio (P/B), use book value to analyze the attractiveness of shares.

Annual Book Value EDAP TMS S.A.

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
- - - - 50.1 M 26.2 M 27.4 M 25 M 25.2 M 24.5 M 14.4 M 15.1 M 9.28 M 8.16 M 8.71 M

All numbers in EUR currency

Indicator range from annual reports

Maximum Minimum Average
50.1 M 8.16 M 21.3 M

Quarterly Book Value EDAP TMS S.A.

2025-Q4 2024-Q4 2023-Q4 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
- 40.9 M 56.9 M 71.6 M - - - 50.1 M - - - 26.2 M - - - 27.4 M - - - 25 M - 24.6 M - 25.2 M - 25.4 M - 24.5 M - 24.4 M - 14.4 M - 13.4 M - 15.1 M - - - 9.28 M - - - 8.16 M - 9.55 M - 8.71 M - - -

All numbers in EUR currency

Indicator range from quarterly reporting

Maximum Minimum Average
71.6 M 8.16 M 26.3 M

Book Value of other stocks in the Medical devices industry

Issuer Book Value Price % 24h Market Cap Country
GenMark Diagnostics, Inc. GenMark Diagnostics, Inc.
GNMK
196 M - - $ 1.77 B usaUSA
AdaptHealth Corp. AdaptHealth Corp.
AHCO
1.53 B $ 13.08 2.19 % $ 1.77 B usaUSA
Allied Healthcare Products Allied Healthcare Products
AHPI
19.7 M - 3.58 % $ 2.21 M usaUSA
BioSig Technologies BioSig Technologies
BSGM
133 M - 37.08 % $ 85.7 M usaUSA
Avinger Avinger
AVGR
-6.2 M - -20.74 % $ 369 K usaUSA
Lianluo Smart Limited Lianluo Smart Limited
LLIT
272 M - 24.59 % $ 44.8 M chinaChina
Axonics Modulation Technologies Axonics Modulation Technologies
AXNX
570 M - - $ 3.31 B usaUSA
LivaNova PLC LivaNova PLC
LIVN
1.2 B $ 63.41 -1.23 % $ 3.46 B britainBritain
Aziyo Biologics Aziyo Biologics
AZYO
27.7 M - 1.37 % $ 20.5 M usaUSA
LENSAR LENSAR
LNSR
-12.2 M $ 5.21 2.36 % $ 62.3 M usaUSA
Pulmonx Corporation Pulmonx Corporation
LUNG
54.1 M $ 1.28 0.79 % $ 52.1 M usaUSA
BIOLASE BIOLASE
BIOL
1.96 M - -13.19 % $ 166 K usaUSA
Obalon Therapeutics, Inc. Obalon Therapeutics, Inc.
OBLN
25.5 M - -5.86 % $ 30.6 M usaUSA
Conformis Conformis
CFMS
54.2 M - - $ 16.4 M usaUSA
Insulet Corporation Insulet Corporation
PODD
1.52 B $ 188.31 -0.66 % $ 13.2 B usaUSA
Cytosorbents Corporation Cytosorbents Corporation
CTSO
5.9 M $ 0.61 -2.58 % $ 38 M usaUSA
Apollo Endosurgery Apollo Endosurgery
APEN
32.6 M - - $ 475 M usaUSA
Cardiovascular Systems Cardiovascular Systems
CSII
249 M - 0.15 % $ 844 M usaUSA
ClearPoint Neuro ClearPoint Neuro
CLPT
28 M $ 11.21 -4.84 % $ 317 M usaUSA
Globus Medical Globus Medical
GMED
4.57 B $ 93.7 -1.23 % $ 12.7 B usaUSA
Sintx Technologies Sintx Technologies
SINT
2.93 M $ 2.35 -4.86 % $ 6.52 M usaUSA
Helius Medical Technologies Helius Medical Technologies
HSDT
2.35 M - - $ 1.28 M usaUSA
Dynatronics Corporation Dynatronics Corporation
DYNT
3.26 M - 14.99 % $ 929 K usaUSA
Eargo Eargo
EAR
101 M - - $ 10.2 M usaUSA
CryoLife, Inc. CryoLife, Inc.
CRY
58.1 M - -4.14 % $ 702 M usaUSA
Electromed Electromed
ELMD
43.2 M $ 26.0 -1.48 % $ 220 M usaUSA
Second Sight Medical Products Second Sight Medical Products
EYES
15.7 M - -0.97 % $ 54.4 M usaUSA
CHF Solutions, Inc. CHF Solutions, Inc.
CHFS
6.23 M - 1.15 % $ 34.5 M usaUSA
Stryker Corporation Stryker Corporation
SYK
22.4 B $ 329.01 0.46 % $ 126 B usaUSA
GBS GBS
GBS
2.81 M - -0.57 % $ 7.12 M usaUSA
Soliton, Inc. Soliton, Inc.
SOLY
243 M - -1.42 % $ 435 M usaUSA
Hancock Jaffe Laboratories, Inc. Hancock Jaffe Laboratories, Inc.
HJLI
2.61 B - -1.98 % $ 98.3 M usaUSA
Itamar Medical Ltd. Itamar Medical Ltd.
ITMR
229 M - 0.03 % $ 1.58 B israelIsrael
Misonix, Inc. Misonix, Inc.
MSON
30.4 M - - $ 462 M usaUSA
Neovasc Neovasc
NVCN
52.2 M - - $ 111 M canadaCanada
OrthoPediatrics Corp. OrthoPediatrics Corp.
KIDS
347 M $ 15.82 -2.29 % $ 371 M usaUSA
Butterfly Network Butterfly Network
BFLY
169 M $ 5.48 2.81 % $ 1.16 B usaUSA
Intersect ENT, Inc. Intersect ENT, Inc.
XENT
550 M - - $ 955 M usaUSA
Delcath Systems Delcath Systems
DCTH
111 M $ 10.84 - $ 388 M usaUSA
Varex Imaging Corporation Varex Imaging Corporation
VREX
487 M $ 12.71 1.44 % $ 526 M usaUSA
IRIDEX Corporation IRIDEX Corporation
IRIX
4.92 M $ 1.08 1.89 % $ 18.3 M usaUSA
Vivos Therapeutics Vivos Therapeutics
VVOS
-1.55 M $ 0.86 2.46 % $ 8.84 M usaUSA
CONMED Corporation CONMED Corporation
CNMD
1.03 B - - $ 1.18 B usaUSA
Inspire Medical Systems Inspire Medical Systems
INSP
781 M $ 55.07 -2.2 % $ 1.62 B usaUSA
Integer Holdings Corporation Integer Holdings Corporation
ITGR
1.75 B $ 85.35 -0.78 % $ 2.96 B usaUSA
PAVmed PAVmed
PAVM
22.3 M $ 8.4 -6.67 % $ 5.63 M usaUSA
Invacare Corporation Invacare Corporation
IVC
771 M - - $ 24.7 M usaUSA
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
EW
10.3 B $ 83.46 -0.82 % $ 48.8 B usaUSA
MiMedx Group MiMedx Group
MDXG
257 M $ 3.34 -2.62 % $ 494 M usaUSA